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Decellularization of Chondrocyte-Encapsulated
Collagen Microspheres: A Three-Dimensional Model
to Study the Effects of Acellular Matrix
on Stem Cell Fate
Hiu-Wa Cheng, B.Eng.,1 Yuen-Kee Tsui, M.Phil.,2 Kenneth M.C. Cheung, M.D.,2
Danny Chan, Ph.D.,3 and Barbara P. Chan, Ph.D.1
Extracellular matrix (ECM) partially constitutes the stem cell niche. Reconstituting the ECM niche in a three-
dimensional (3D) configuration will significantly enhance our understanding of how stem cells interact with and
respond to the ECM niche. In this study, we aimed to reconstitute a glycosaminoglycan (GAG)-rich ECM using a
microencapsulation technology, produce acellular matrix using a decellularization technique, and investigate the
effect of acellular matrix on stem cell fate by repopulating the matrix with human mesenchymal stem cells
(hMSCs). We demonstrated that porcine chondrocytes were able to deposit a GAG-rich ECM within the 3D
collagenmicrosphere. All decellularization treatment groups resulted in significant removal of chondrocyte nuclei,
but acellular matrix was only achieved using 2% sodium deoxycholate. Nevertheless, decellularization resulted in
significant loss in GAG content in almost all treatment groups, and the 2% sodium deoxycholate groupwas able to
preserve about 40% of the GAGs compared with the control group. We further demonstrated that hMSCs seeded
onto the decellularizedmicrospheres were able to survive and penetrate into the centre, while hMSCs seeded in the
acellular matrix showed positive immunostaining against sox9, indicating that they may be differentiating toward
the chondrogenic lineage without the need to supplement the chondrogenic differentiation medium.
Introduction
The stem cell microenvironment or niche is collec-tively made up of the external signals that control stem
cell fate, that is, that either keep them as stem cells or direct
them along particular differentiation pathways.1 These ex-
ternal control signals include not only the well-known
secreted factors and cell–cell interactions but also the extra-
cellular matrix (ECM).1 ECM serves as the structural sup-
port for stem cells to attach and survive and also controls
the stem cell fate by altering the cell–matrix interactions.2,3
Moreover, ECM sequesters, modulates, and potentiates
secreted factors within the stem cell niche such as binding
of bone morphogenetic protein 2 to glycosaminoglycans
(GAGs)4 and enhancing the basic fibroblast growth factor
activities by heparin sulfate proteoglycans.5,6 Existing ex-
perimental models studying the effect of particular ECM on
stem cell fate are usually based on supplementing the free
ECM to the culture medium6,7 or coating the substratum of
the culture chamber with the ECM.8 Nevertheless, it has re-
cently been demonstrated that cells interact with their ECM
differently when they are in a three-dimensional (3D) con-
figuration compared with in 2D monolayer cultures.9 As a
result, experimental models reconstituting the ECM micro-
environment or niche in a 3D configuration will significantly
enhance our understanding of how stem cells interact with
and respond to the ECM niche before scaffolding strategies
with appropriate controls over the stem cell fates can be
developed.10
Acellular ECM processed from allogenic or xenogenic
tissues is most nature simulating and has been used as scaf-
folds for the tissue engineering of many tissues, including
heart valves,11,12 vessels,13 nerves,14 tendons, and ligaments.15
Decellularization is a technique for removing cellular com-
ponents from native tissues and is usually achieved by a
combination of physical, chemical, and enzymatic meth-
ods.16–18 This technique removes the allogenic or xenogenic
cellular antigens from the tissues, as they are the sources for
immunogenicity on implantation, but it preserves the ECM
components, which are highly conserved among species and
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therefore well-tolerated immunologically. Moreover, growth
factors that may facilitate cell growth and remodeling may
be preserved in the decellularized matrix.17 Decellularized
tissues are usually used directly for replacement of defective
tissues but are seldom used to investigate the effects of the
ECM microenvironment on stem cells. This is because re-
populating decellularized native tissues with stem cells is
always problematic due to the limited cell penetration and
ECM porosity.
Recently, we developed a collagen microencapsulation
technique19 that entraps living cells in a self-assembled
meshwork of native collagen fiber, forming cell–collagen
microspheres. The matrix meshwork provides 3D support
for cells such as human mesenchymal stem cells (hMSCs)19
and embryonic stem cells20 to survive, proliferate, migrate,
and differentiate. We also demonstrated that stem cells em-
bedded within the meshwork are able to remodel the matrix
meshwork by depositing cell-specific ECM when they are
exposed to differentiation signals. Examples include GAG
production by hMSCs undergoing chondrogenic differenti-
ation21 and calcium deposition by hMSCs undergoing oste-
ogenic differentiation.22
In this study, we aimed to use the microencapsulation
technology together with the decellularization technique to
establish a 3D experimental model for investigation of the
effects of the cell-specific ECMmicroenvironment or niche on
stem cell fate. Specifically, we aimed to reconstitute a GAG-
rich ECM in a 3D configuration by encapsulating and cul-
turing porcine chondrocytes in the collagen meshwork,
produce acellular matrix by decellularizing the chondrocytes
with partial retention of the newly deposited matrix, and
investigate the effects of the acellular matrix on stem cell fate
by repopulating the decellularized matrix with hMSCs.
Materials and Methods
Culture of primary porcine chondrocytes
Primary porcine chondrocytes were kindly provided by
the Department of Orthopaedics and Traumatology, the
University of Hong Kong. Chondrocytes at P0 to P3 were
used in this study because chondrocytes of later passages
may de-differentiate. Chondrocytes were cultured in full
medium consisting of Dulbecco’s modified Eagle’s medium–
high glucose (DMEM-HG), 10% fetal bovine serum (FBS),
penicillin 100U=mL, streptomycin 100mg=mL, sodium hy-
drogen carbonate 1.875mg=mL, 0.02M 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), 1mM sodium
pyruvate, and L-glutamine 0.29mg=mL. The final pH of the
medium was adjusted to 7.4 with 1N sodium hydroxide.
Chondrocytes were isolated by adherence selection for 24 h
in cultures. Cells were maintained in full medium with re-
plenishment every 3 days. Chondrocytes at subconfluence
were detached by 0.25% trypsin=ethylenediaminetetraacetic
acid (EDTA) for subsequent microencapsulation.
Microencapsulation of chondrocytes
Chondrocytes were microencapsulated in collagen as
previously reported.19 In brief, ice-cold rat tail collagen type I
(Becton Dickenson, Franklin Lakes, NJ) was neutralized with
1N sodium hydroxide and was further diluted with full
medium to give a final concentration of 2mg=mL. Aliquots
of chondrocytes at P0 to P3 in full medium were rapidly
mixed with the neutralized collagen solution, resulting in
cell–matrix mixtures with final cell densities of 500, 2500, and
12,500 cells=2.5 mL droplets. Liquid droplets were dispensed
into a 35mm diameter Petri dish (Sterlin, Stone, United
Kingdom) with UV irradiated parafilm covering the sub-
stratum. After incubating for 1 h, the liquid droplets gelated
to form solid chondrocyte–collagen microspheres, which
were then gently flushed into a Petri dish using full medium
and cultured for 7 days before decellularization.
Decellularization of chondrocyte–collagen
microspheres
Chondrocyte–collagen microspheres were decellularized
by incubation with different detergents at various concen-
trations, specifically 2% and 3% Triton X-100, and 0.5%, 1%,
and 2% sodium (Na) deoxycholate. For each detergent treat-
ment group, 100 microspheres were immersed in 2mL of
chemical extraction solutions in 35mm diameter Petri dishes
for 1 h at room temperature. Microspheres were rinsed with
phosphate-buffered saline (PBS) five times to remove excess
detergent before subsequent evaluation and hMSC seeding
experiment.
Histological evaluation of chondrocyte–collagen
microspheres
Microspheres were fixed in 4% paraformaldehyde for 3 h.
They were then washed with PBS again to remove excess
paraformaldehyde. The fixed microspheres were then em-
bedded in agarose and subsequently stored in 30% sucrose
solution at 48C overnight. The sample was then embedded in
optimal cutting temperature (OCT) for cryosectioning. Sec-
tions of 10mm thick were prepared for routine hematoxylin
and eosin (H&E) staining to reveal the cell morphology and
Alcian blue staining with Nuclear Fast Red counterstains to
reveal the GAG-rich region.
Enumeration of cell nuclei
in decellularized microspheres
Cell nuclei were counted in H&E-stained sections using
the image analysis software MetaMorph. The same observer
analyzed all the samples in the study in a randomized and
blind fashion. Cell densities in the samples were calculated,
and the percent reduction in cell density in treated samples
(relative to the untreated controls) was determined. In brief,
the images were converted to grayscale before analysis
for better contrast. An area of *0.15mm2, which accounts
for more than 95% of the section, was analyzed. Cell nuclei
ranging from 3 to 289 were counted. Four sections with
40magnification in the control and each experimental
group were analyzed, and the mean was taken as the cell
nuclei density (cells=mm2).
Quantification of sulfated GAG content
in decellularized microspheres
For each treatment group and the control group, 10 mi-
crospheres per sample were placed in a phosphate buffer at
pH 6.5 (50mM phosphate buffer, 5mM EDTA, and 5mM
L-cysteine) containing 300 mg=mL papain to solubilize the
proteoglycans. Digestion was carried out at 608C overnight.
698 CHENG ET AL.
A 1,9-dimethylmethylene blue dye-binding assay for sul-
fated GAGs, using chondroitin sulfate as a standard, was
performed on the digested samples.23 Absorbance at 656 nm
was then measured using a microplate reader (Safire 2;
Tecan, Mannedorf, Switzerland). The quantities of GAGs in
samples were determined using a calibration curve prepared
by chondroitin sulfate standard with a linear region between
0.125 and 4mg=200mL.
Culture of hMSCs
hMSCs were kindly provided by Dr. GCF Chan from the
Department of Paediatrics and Adolescent Medicine, the
University of Hong Kong. Bone marrow aspirates were col-
lected from healthy bone marrow donors with informed
consent. All procedures were approved by the Combined
Clinical Ethics Committee of the University of Hong Kong
and the Hong Kong West Cluster Hospitals of the Hospital
Authority. hMSCs were isolated and cultured as previously
reported.24 Mononuclear cells were collected after Ficoll-
Hypaque gradient separation and cultured in full medium
consisting of DMEM-low glucose (DMEM-LG) (1 g=L), 10%
FBS, penicillin 100U=mL, streptomycin 100mg=mL, and
2mM L-glutamine. hMSCs were selected by adherence after
24 h and maintained in full medium with regular replace-
ment. Cells were detached by 0.05% trypsin=25mmol EDTA
and subcultured as P1. hMSCs at P4 were seeded onto the
decellularized microspheres.
hMSC seeding on the decellularized microspheres
The decellularized microspheres were washed with PBS
and were equilibrated with the hMSC full medium consist-
ing of DMEM-LG with 10% FBS for 1 h before cell seeding.
They were then transferred to a parafilm-coated Petri dish
without supplementation of medium, and 5 mL of hMSC
solution at a concentration of 1106 cell=mL was directly
dropped onto each microsphere. hMSCs were then allowed
to adhere to the microspheres for 30min before careful
supplementation with hMSC medium for further culture.
Cell viability of hMSCs seeded in the microspheres
hMSCs were cultured for 7, 14, and 21 days before anal-
ysis for cell viability and histological and immunohisto-
chemical evaluation. Microspheres were labeled with 2mM
calcein AM and 4mM ethidium homodimer-1 for simulta-
neous staining of live and dead cells, respectively (LIVE=
DEAD Viability=Cytotoxicity kit; Molecular Probes, Invitro-
gen, Carlsbad, CA). Briefly, the microspheres were washed
with PBS to remove all medium, and incubated with the two
fluorescent dyes for 45min in darkness. The microspheres
were subsequently washed again with PBS to remove all
labeling medium. Finally, the cell viability of the micro-
spheres was examined using a LEICA DMIRB inverted
fluorescent microscope equipped with a SPOT FLEX camera.
Immunohistochemical evaluation
of chondrogenic lineages
Immunohistochemistry against sox9 was used to reveal
the chondrogenic lineage of hMSCs in the seeding experi-
ment. Cryosections of 10 mm thickness were incubated with
0.5% pepsin in 5mM HCl at 378C for 30min for antigen
retrieval. Tissue sections were then treated with 3% H2O2
in methanol for 30min to block endogenous peroxidase ac-
tivity. Rabbit anti-sox9 polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) was used as a primary an-
tibody, diluted to 1:500 in 2% bovine serum albumin in PBS.
Sections were incubated with primary antibody at 48C
overnight before incubation with the secondary antibody,
the anti-rabbit immunoglobulin, which was diluted to 1:2000
in 2% bovine serum albumin in PBS, for 30min at room
temperature. The Vectastain ABC kit (Vector Laboratories,
Burlingame, CA) was used to observe the positive signal,
and hematoxylin was used as the counterstain.
Data presentation and statistical analysis
Quantitative results such as cell nucleus density and
quantity of GAGs were reported as mean standard devia-
tion. One-way ANOVA with appropriate post hoc tests were
used to reveal differences among different treatment groups.
A significance level was set at 0.05, and SPSS 16.0 was used
for the analysis.
Results
Characterization of chondrocyte-encapsulated
microspheres
Figure 1 shows the morphological, histological, histochem-
ical, and immunohistochemical characterization of chondrocyte-
encapsulated microspheres. Phase contrast microscopy showed
that porcine chondrocytes were entrapped in 3D collagen
microspheres. H&E staining showed chondrocytes resided in
lacunae in the collagen matrix of the microspheres. Alcian
blue staining showed that chondrocytes were able to deposit
GAGs in the ECM of the microspheres. Immunohisto-
chemical staining of sox9 in nuclei confirmed the identity of
the chondrocytes.
Removal of cell nuclei from chondrocyte-entrapped
microspheres
Figure 2 shows the histological staining of chondrocyte-
entrapped collagen microspheres in different treatment
groups. Chondrocytes, stained blue in H&E staining, were
randomly distributed in collagen microspheres without de-
cellularization treatment (Fig. 2A). Chondrocyte-entrapped
collagen microspheres treated with Triton X-100 at different
concentrations (Fig. 2B, C) showed dramatically reduced cell
density compared with the control group, but cell nuclei and
cytoplasm were still distinct. As for Na deoxycholate, 0.5%
and 1% also significantly reduced the cell density compared
with the control group, but again cell nuclei and cytoplasm
were still distinct. Increasing the concentration to 2.0% suc-
cessfully removed all cell nuclei in the microspheres, al-
though some cytoplasm was still visible. The number of
nuclei in different treatment groups is shown in Figure 3.
Treatments with Triton X-100 and lower concentration of Na
deoxycholate resulted in at least a 50% reduction in the
number of nuclei per unit area in the microspheres, while
there were less than 15 cells per unit area in the 2% Na
deoxycholate group. One-way ANOVA showed significant
difference among all groups ( p< 0.001), while post hoc tests
showed that all treatment groups were significantly different
from the control groups ( p< 0.05).
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Cell viability of chondrocyte-entrapped microspheres
Figure 4 shows the cell viability in chondrocyte-entrapped
microspheres. Inmicrosphereswithout any chemical treatment
(Fig. 4A), the majority of cells were alive (green cytoplasm),
while only a few dead cells (red nuclei) were found. In mi-
crospheres treated with 2% Triton X-100 (Fig. 4B), all cells were
dead, and only red nuclei could be located. In microspheres
treated with 2% Na deoxycholate (Fig. 4C), no live cells re-
mained, and no nuclei could be located due to their complete
removal.
Preservation of GAG content in
chondrocyte-entrapped microspheres
Figure 5 shows the representative Alcian blue staining for
GAG-rich regions and the amount of GAGs in microspheres
of different treatment groups. About 2% of Triton X-100 was
able to preserve at least 90% of GAGs in microspheres
compared with the control group, while increasing the con-
centration to 3% reduced the GAG content to about only 65%
of the control. For Na deoxycholate, low concentration at
0.5% was able to preserve more than 90% of the GAG content
in the microsphere and increasing it to 1% also preserved
more than 80% of the GAGs. However, 2% Na deoxycholate
only retained about 40% of the GAGs compared with the
control group. One-way ANOVA showed statistically sig-
nificant difference among different groups ( p< 0.001), while
post hoc tests showed that all groups except the 2% Triton
X-100 group had statistically significant loss of GAGs
( p< 0.05) compared with the control group.
Morphology of hMSC-seeded
decellularized microspheres
Figure 6 shows the morphology of hMSC-seeded micro-
spheres, which have been decellularized by different che-
mical treatments. hMSCs were able to grow and penetrate
into the center of the decellularized microspheres in both
the Triton X-100 and Na deoxycholate groups. Moreover, the
cellularity continuously increased over the 3 weeks of culture
time in both groups.
Cell viability of hMSCs seeded
on decellularized microspheres
Figure 7 shows the cell viability staining for hMSCs
seeded on the decellularized microspheres. Both 2% Triton
X-100 and 2% Na deoxycholate–treated microspheres were
able to support cell survival, and most hMSCs were found
viable after culture for 7 days.
FIG. 1. Microscopic charac-
terization of the chondrocyte–
collagen microspheres. (A)
Phase contrast microscopy;
(B) H&E staining; (C) Alcian
blue staining; (D) immuno-
histochemistry of sox9. Color
images available online at
www.liebertonline.com=ten.
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Sox9 immunohistochemistry of hMSC-seeded
decellularized microspheres
Figure 8 shows the immunohistochemical staining for sox9
in hMSC seeded on the decellularized microspheres with
acellular matrix. hMSCs encapsulated in collagen gel without
exposure to chondrogenic differentiation signals showed
negative staining for sox9, while hMSCs seeded in the acel-
lular matrix in the microspheres produced by decellulariza-
tion with 2% Na deoxycholate showed positive staining in
cell nuclei after 7, 14, and 21 days of culture.
Alcian blue staining of hMSC-seeded
decellularized microspheres
Figure 9 shows the Alcian blue staining of the hMSC-
seeded decellularized microspheres at 7, 14, and 21 days.
Increased cellularity with large cell clusters was found in
these microspheres in later time points at 14 and 21 days,
suggesting that the seeded hMSC could proliferate and
grow. Moreover, the seeded cells remodeled the microsphere
matrix by digesting away the old GAG-rich matrix, as shown
by the reduced proportion of Alcian blue–stained regions (*)
in particular on days 14 and 21. In the mean time, Alcian
blue–stained regions could be located within the region with
newly proliferated cell clusters (arrows).
Discussion
This study demonstrates the possibility of producing
acellular matrix by first encapsulating and culturing chon-
drocytes in a template collagen fibrous meshwork and then
completely removing the chondrocytes with partial retention
of the newly deposited matrix. This study also demonstrates
successful repopulation of the acellular matrix with hMSCs
FIG. 2. Representative H&E staining of the chondrocyte–collagen microspheres in different decellularization treatment
groups. (A) Control samples of collagen embedded with chondrocytes; (B) samples treated with 2% Triton X-100; (C) samples
treated with 3% Triton X-100; (D) samples treated with 0.5% Na deoxycholate; (E) samples treated with 1% Na deoxycholate;
(F) samples treated with 2% Na deoxycholate. Color images available online at www.liebertonline.com=ten.
FIG. 3. Bar chart showing the cell nuclei per unit area in
chondrocyte–collagen microspheres in different decellular-
ization treatment groups. Data represent mean standard
deviation for n¼ 4.
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and provides evidence of the commitment of hMSCs re-
populated on the acellular matrix toward chondrogenic lin-
eages.
Collagen meshwork acts as the template
for encapsulated cells to deposit new matrices
Collagen microspheres provide 3D fiber meshwork,19
which serves as the template to allow cells to remodel and
lay down new ECM within the meshwork.21,22 This study
showed that chondrocytes were able to make a large amount
of GAGs within the collagen meshwork. Moreover, our
previous reports showed that hMSCs undergoing chondro-
genic differentiation laid down GAGs and type II collagen,21
while hMSCs undergoing osteogenic differentiation laid
down calcium deposits22 within the template collagen mesh-
work in the microspheres. As a result, this microencapsula-
tion technique provides a 3D template for various types of
cells to reconstitute their specific matrices and can thus be
used to study the effects of such a cell-specific matrix mi-
croenvironment on the fate of stem cells.
Na deoxycholate is a better decellularization
chemical than Triton X-100
Complete decellularization is essential to avoid the im-
munogenicity elicited by the cellular remnants. Na deox-
ycholate is apparently a better decellularization chemical
than Triton X-100. The amount of cells removed by Na
deoxycholate is extremely sensitive to the dosage of this
chemical, and increasing the concentration to 2% effectively
removed all cell nuclei, although the newly deposited GAGs
were only partially retained. Further optimization is required
to retain more GAGs by increasing the initial chondrocytes
FIG. 4. Live and dead
staining of chondrocyte–
collagen microspheres in
different decellularization
treatment groups. (A)
Control; (B) 2% Triton
X-100; (C) 2% Na
deoxycholate. Color im-
ages available online at
www.liebertonline
.com=ten.
FIG. 5. Alcian blue stain-
ing and quantification of
glycosaminoglycans
(GAGs) in chondrocyte–
collagen microspheres of
different decellularization
treatment groups; (A)
control; (B) 2% Na
deoxycholate group; (C)
bar chart showing the
amounts of GAGs in
microspheres of different
treatment groups. Data
represent mean standard
deviation for n¼ 7. Color
images available online at
www.liebertonline
.com=ten.
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seeding density in the microspheres, lengthening the culture
period of chondrocytes on the microspheres, or using other
extraction chemicals and protocols. Higher concentration at
4% was not used because it dissolved all microspheres (data
not shown). On the other hand, the amount of cells removed
is less sensitive to Triton X-100 treatment as concentration
lower than 2% did not significantly remove cells (data not
shown), 2% removed only half of the nuclei, and increasing
concentration to 3% did not further increase the amount of
cells removed. Compared with native tissues, which have
intact structures other than collagen to provide further
mechanical support and resistance to chemical treatment,
these collagen microspheres need milder decellularization
protocols and shorter decellularization time because pro-
teoglycans are highly water soluble and are easily lost into
the surrounding solutions.25
FIG. 7. Live and dead
staining of decellularized
chondrocyte–collagen
microspheres repopulated
with hMSCs. (A) Micro-
spheres decellularized by 2%
Triton X-100 showed both live
hMSCs (green) and remnant
chondrocyte nuclei (red); (B)
Microspheres decellularized
by 2% Na deoxycholate
showed only live hMSCs
(green). Color images
available online at www
.liebertonline.com=ten.
FIG. 6. Representative H&E staining of human mesenchymal stem cells (hMSCs) seeded on decellularized microspheres.
(A–C) hMSCs seeded on 2% Triton X-100–treated microspheres for 7, 14, and 21 days, respectively; (D–F) hMSCs seeded on
2% Na deoxycholate–treated microspheres for 7, 14, and 21 days, respectively. Color images available online at www
.liebertonline.com=ten.
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Fate of hMSCs seeded in the
decellularized microspheres
hMSCs are able to penetrate into the center of the decel-
lularized microspheres and repopulate the whole micro-
sphere, suggesting that even though there is a minute
amount of residual decellularization chemical, it does not
induce adverse effects on the seeded hMSCs. Positive stain-
ing of sox9, the intranuclear marker for cells committing to
chondrogenic lineage, has been found in hMSCs seeded on
microspheres decellularized by Na deoxycholate for 7, 14,
and 21 days, indicating that the hMSCs may be differen-
tiating toward the chondrogenic lineage in the acellular
matrix without the need to supplement the chondrogenic
FIG. 8. Immunohistochemistry of sox9 of hMSCs seeded on decellularized microspheres. (A) Negative control using hMSC–
collagen gel cultured for 7 days; (B) positive control using chondrocyte–collagen microspheres cultured for 7 days; (C)
negative staining in 2% Na deoxycholate decellularized microspheres (no hMSC seeding) for 7 days; (D–F) positive staining
in hMSC-seeded 2% Na deoxycholate decellularized microspheres for 7, 14, and 21 days, respectively. Color images available
online at www.liebertonline.com=ten.
FIG. 9. Representative Alcian blue staining of hMSCs seeded on 2% Na deoxycholate decellularized microspheres. hMSCs
seeded for 7 (A), 14 (B), and 21 (C) days. Color images available online at www.liebertonline.com=ten.
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differentiation medium. Only Na deoxycholate–treated mi-
crospheres were used in this part of the study because this
treatment completely removed all cell nuclei of porcine
chondrocytes and successfully produced an acellular matrix.
As a result, any positive sox9 staining would be attributable
to the newly seeded hMSCs. ECM markers for chondrogenic
lineages such as type II collagen and proteoglycans were not
used in this study because it is impossible to distinguish the
newly deposited ECM by the differentiating hMSCs from the
residual ECM components synthesized by the porcine
chondrocytes before decellularization. Commitment of
hMSCs to chondrogenic lineage may be due to the ECM
microenvironment deposited by the porcine chondrocytes
and possibly remnant growth factors in the matrix. Previous
studies with a similar approach using decellularized matrix
showed that osteoblast-specific matrix induced MSCs to
commit to the osteogenic lineage.26,27 Corroborating with
these studies, our results suggest the importance of recon-
stituting a 3D cell-specific acellular matrix environment to
regulate stem cell fate and contribute to further development
of biomimetic scaffolding approaches.
Conclusion
Porcine chondrocytes microencapsulated in collagen mi-
crospheres were able to deposit a GAG-rich ECM microen-
vironment. An optimized decellularization protocol has been
established to completely remove the encapsulated chon-
drocytes with partial retention of the GAG-rich matrix. The
decellularized microspheres were able to be repopulated
with hMSCs, and the commitment of hMSCs to chondro-
genic lineage in the acellular matrix has been demonstrated.
This study provides an excellent 3D model to study the cell-
specific acellular matrix microenvironment or niche and the
effects on stem cells.
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